Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Factors Causing Multiple Disabilities Among Children-The Pharma-Media Alliance Never Wants The Public To Know-: Unveils Qadhi A.Z. Al-Hafi

Prof. Aurangzeb Hafi's Polygonal Investigative Research-work Systematically Debunks 'Terrifying Facts' Behind the 'Birth Defects' among the Children Worldwide


News provided by

Professor Qadhi Aurangzeb Al Hafi

Jul 29, 2014, 11:01 ET

Share this article

Share toX

Share this article

Share toX

LAHORE, Pakistan, July 29, 2014 /PRNewswire-USNewswire/ -- Evidence-based, well documented statistical records of nearly 685-765 million disables of the world, when correlated with data analysis, quite shockingly endorse enough-provable linkages and incontestable 'causal relationships' between fetal 'iatro-teratogenecity' and multiple forms of disabilities among newly born and unborn babies.

Photo - http://photos.prnewswire.com/prnh/20140729/130780
Logo - http://photos.prnewswire.com/prnh/20140729/130779

Continue Reading
DUHS Press Conference (PRNewsFoto/Professor Qadhi Aurangzeb Al...)
DUHS Press Conference (PRNewsFoto/Professor Qadhi Aurangzeb Al...)
Sir Aurangzeb Hafi logo (PRNewsFoto/Professor Qadhi Aurangzeb Al...)
Sir Aurangzeb Hafi logo (PRNewsFoto/Professor Qadhi Aurangzeb Al...)

The term 'iatro-teratogenesis' refers to the deadly spectacle-manifestations and pandemic outbreaks of 'irrational medications' that are administered during pregnancy or in lactation periods.

Notably, most of the prevalent drug-formulations are predominantly based on complex chemical-compositions, which, essentially, do pose serious threats to the physio-chemical synchrony of fetal tissues—thus, eventually leaving the baby with severe vulnerabilities of life-long disabilities-- both, structural as well as functional. 

Not only are these embryonically 'non-compatible' hefty drug-formulations hard to be absorbed by the fetal tissues, but also their chemical structures remain intransigently 'tough-enough' to be broken down and processed by the fetal cells in the same timeframe and interval-break-intermissions, as those of the mother's body cells.

During this course of ultimate 'dis-synchrony' in complex dynamic-interplay of chemicals, the fetal body cells are left with no margin-latitudes other than bearing heavy toxic burdens at the very initial stages of cell-formations and organogenesis—and, ultimately persisting on considerably devastating complexities of physical and mental abnormalities.

At the very core of the problem, underlying source-reason is 'irrational & obscured medication'— Irrational, because; how can it be rationalized to alleviate the common-cold symptoms, or to relieve the temporary nasal-achings or ordinary headaches of a mother at the 'very cost of life-long disabilities' of the baby?

And obscured, understandably, due to the identical fact that most of the prevalent drug-compositions are, embryonically non-compatible, but nonetheless these are administered during pregnancy—because they do bear the fascinating enough 'safety-signs' like '100% secure for both, 'the mother and the baby' and 'no adverse-effects noted'...etc.

"The chemical mechanism of these drugs is not that simple as publicized by these 'allegedly false' and massively 'misleading safety-claims', that are made by the corporate controllers of medical world—the pharmaceutical profiteers, who promote 'these practices' through highly-crafted and 'well-tailored' campaigns involving 100% biased, pre-inclined research studies that are funded, predisposed and 'course-plotted' by the same parties, and then publicized by these 'profiteers-backed' media"... points out the research-study.

"Such drugs and chemical-compositions must be brought under strict international legislation, in order to safeguard the lives of massive proportions of 'unborn babies', that are prone to predisposal of detrimental devastations" pleads the research cessation.

This forthrightly stark 'crux' of the devastating 'perplex-crisis' has been documented by a groundbreaking research on disability-prevention perspectives-foci.

The research study, that is going to change the way the world looks at the 'phenomenon of disability', quite evocatively brings forth sensitive questions and key concerns to be addressed by the global hierarchies including the UN, and henceforth, calls for international legislation on the subject matter.

The benchmark pinnacle research document is primed for over 1900 universities of the globe, and is an outcome of nearly 1.5 decades of inquiry-probings on the subject-matter by the multidisciplinary arch-researcher Professor Qadhi Aurangzeb Al-Hafi. It was demonstrated through a multi-academic scientific research colloquia, at Higher Education Commission, Pakistan.  The colloquia consisted of 9-thematic orientations, 17-confluences, 10-symposia and 19-scientific demonstrations.

Key concerns of Dr. Aurangzeb Hafi's research are circumscribed in the 'frame-of-reference' of 'disability-prevention'—'before-the-occurrence', by addressing the diverse spectrums of underlying 'causal-factors'.

Dr. Hafi served as head of several projects concerning the disabled population during Tsunami-2004, and maintained liaisons with UN and concerned agencies thereof.

Professor Hafi is also credited for identifying the 'teratogenic effect' of the toxic-remnants, posed over the modern sewage-system, resulting in underground water-reserves' hydro-toxification.

By virtue of these benevolent and worthy contributions, Pakistan, incontrovertibly, now stands on the verge of becoming the world's 'research capital', in the disability-centered scholastic realm.

The cutting-edge research is a 'judiciously upright' and a 'humanely sane' call to the collective conscience of the world, to come forth to raise the voices for those who are unable to raise their voices for themselves—the babies, yet unborn—but perilously prone to severe lifelong disabilities—the voiceless—the left-behind population living with multiple forms of disabilities—the neglected part of the society.

Find out more information about Professor Hafi's research at www.hafiinitiatives.org/.

Media Contact:
Dr. F. M. Bhatti
0092-3066630993
0092-3128808800

SOURCE Professor Qadhi Aurangzeb Al Hafi

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.